Literature DB >> 23526867

Protocol Development Program: A Novel Approach to Overcoming Barriers to Clinical Research.

Tracey J Miller, Vali S Sevastita, Doreen G Chaitt, Jorge A Tavel, Jerome F Pierson.   

Abstract

Entities:  

Year:  2013        PMID： 23526867      PMCID： PMC3606026     

Source DB:  PubMed          Journal:  Monitor (Assoc Clin Pharmacol)        ISSN： 1088-2111


× No keyword cloud information.
  9 in total

1.  Enthusiasm for clinical and translational research at Johns Hopkins: CTSA program reaches out to the community in a variety of ways.

Authors:  Daniel E Ford; Andrea Lively
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

2.  Using research metrics to improve timelines: proceedings from the 2nd Annual CTSA clinical research management workshop.

Authors:  Tesheia Johnson; Michael Joyner; Fred Depourcq; Marc Drezner; Raymond Hutchinson; Kara Newton; Kathleen T Uscinski; Kim Toussant
Journal:  Clin Transl Sci       Date:  2010-12       Impact factor: 4.689

3.  Steps and time to process clinical trials at the Cancer Therapy Evaluation Program.

Authors:  David M Dilts; Alan B Sandler; Steven K Cheng; Joshua S Crites; Lori B Ferranti; Amy Y Wu; Shanda Finnigan; Steven Friedman; Margaret Mooney; Jeffrey Abrams
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

4.  Assessing the impact of protocol design changes on clinical trial performance.

Authors:  Kenneth A Getz; Julia Wenger; Rafael A Campo; Edward S Seguine; Kenneth I Kaitin
Journal:  Am J Ther       Date:  2008 Sep-Oct       Impact factor: 2.688

5.  Building a protocol expressway: the case of Mayo Clinic Cancer Center.

Authors:  Terre A McJoynt; Muhanad A Hirzallah; Daniel V Satele; Jason H Pitzen; Steven R Alberts; S Vincent Rajkumar
Journal:  J Clin Oncol       Date:  2009-06-29       Impact factor: 44.544

6.  Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.

Authors:  David M Dilts; Alan B Sandler
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

7.  A National Cancer Clinical Trials Network: recommendations from the Institute of Medicine.

Authors:  Sharyl J Nass; Erin Balogh; John Mendelsohn
Journal:  Am J Ther       Date:  2011-09       Impact factor: 2.688

8.  Costs and benefits of the national cancer institute central institutional review board.

Authors:  Todd H Wagner; Christine Murray; Jacquelyn Goldberg; Jeanne M Adler; Jeffrey Abrams
Journal:  J Clin Oncol       Date:  2009-10-19       Impact factor: 44.544

9.  Project Zero Delay: a process for accelerating the activation of cancer clinical trials.

Authors:  Razelle Kurzrock; Susan Pilat; Marcel Bartolazzi; Dwana Sanders; Jill Van Wart Hood; Stanley D Tucker; Kevin Webster; Michael A Mallamaci; Steven Strand; Eileen Babcock; Robert C Bast
Journal:  J Clin Oncol       Date:  2009-08-03       Impact factor: 44.544
  9 in total
  1 in total

1.  Activating clinical trials: a process improvement approach.

Authors:  Diego A Martinez; Athanasios Tsalatsanis; Ali Yalcin; José L Zayas-Castro; Benjamin Djulbegovic
Journal:  Trials       Date:  2016-02-24       Impact factor: 2.279
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.